66 related articles for article (PubMed ID: 1339986)
21. Comparison of two experimental binary ethylenimine (BEI) inactivated Newcastle disease oil-emulsion vaccines.
Reddy GS; Srinivasan VA
Acta Virol; 1991 Apr; 35(2):196-9. PubMed ID: 1681718
[TBL] [Abstract][Full Text] [Related]
22. Is there a benefit from an early booster vaccination in the control of equine influenza?
Heldens JG; van Loon AA; van de Zande S
Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
[TBL] [Abstract][Full Text] [Related]
23. Development of an inactivated vaccine against infectious laryngotracheitis (ILT)--serological and protection studies.
Barhoom S; Forgacs A; Solyom F
Avian Pathol; 1986; 15(2):213-21. PubMed ID: 18766521
[TBL] [Abstract][Full Text] [Related]
24. A single dilution enzyme-linked immunosorbent assay for the quantitative detection of antibodies to African horsesickness virus.
Williams R
Onderstepoort J Vet Res; 1987 Mar; 54(1):67-70. PubMed ID: 3587930
[TBL] [Abstract][Full Text] [Related]
25. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
[TBL] [Abstract][Full Text] [Related]
26. Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines.
du Plessis M; Cloete M; Aitchison H; Van Dijk AA
Onderstepoort J Vet Res; 1998 Dec; 65(4):321-9. PubMed ID: 10192846
[TBL] [Abstract][Full Text] [Related]
27. Equine vaccine for West Nile virus.
Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
[TBL] [Abstract][Full Text] [Related]
28. Evaluation in swine of a subunit vaccine against pseudorabies.
Maes RK; Schutz JC
Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
Folitse R; Halvorson DA; Sivanandan V
Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
[TBL] [Abstract][Full Text] [Related]
30. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
31. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
32. The choice of adjuvants in Mycoplasma vaccines.
Garba SA; Terry RJ; Adegboye DS; Lamorde AG; Abalaka JA
Microbios; 1989; 57(230):15-9. PubMed ID: 2661969
[TBL] [Abstract][Full Text] [Related]
33. [Recent studies on Aujesky's dissease in pigs and cattle (author's transl)].
de Leeuw PW; Tiessink JW
Tijdschr Diergeneeskd; 1980 Sep; 105(17):689-94. PubMed ID: 6252655
[TBL] [Abstract][Full Text] [Related]
34. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
35. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
36. African horse-sickness killed-virus tissue culture vaccine.
Ozawa Y; Bahrami S
Can J Comp Med Vet Sci; 1966 Nov; 30(11):311-4. PubMed ID: 4226381
[TBL] [Abstract][Full Text] [Related]
37. Future international management of African horse sickness vaccines.
House JA
Arch Virol Suppl; 1998; 14():297-304. PubMed ID: 9785514
[TBL] [Abstract][Full Text] [Related]
38. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
Nair SP; Sen AK
Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
[TBL] [Abstract][Full Text] [Related]
39. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
Platt R; Coutu C; Meinert T; Roth JA
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
[TBL] [Abstract][Full Text] [Related]
40. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
